Associated Papers
Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.
Alhazzani A et al.
Frontiers in Neurology, 2021
Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland.
Basavaraju U et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ecp), 2015
Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population.
Sitarek P et al.
Dna and Cell Biology, 2012
Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC et al.
Oral Oncology, 2008
COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
Moons LM et al.
The American Journal of Gastroenterology, 2007
Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach.
Candore G et al.
Mechanisms of Ageing and Development, 2007
Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.
Candore G et al.
Annals of the New York Academy of Sciences, 2006
Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.
Siezen CL et al.
Pharmacogenetics and Genomics, 2006
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2005
Select a paper to view details